Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Introduction: Generalized anxiety disorder (GAD) often begins during adolescence or early
adulthood and persists throughout the lifespan. Randomized controlled trials support the …

Introduction: Anxiety disorders are among the most prevalent and disabling psychiatric
disorders in the United States and worldwide. Basic research has provided critical insights …

Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …

Background Anxiety disorders are common and disabling conditions, with a lifetime
prevalence of 17% in the general population. Due to high rates of treatment resistance, there …

Generalized anxiety disorder (GAD) is characterized by persistent and excessive worry.
Around half of the patients treated for GAD will fail to respond to initial treatment. Treatment …

Atypical antipsychotics (AAs) may play a role in the treatment of anxiety disorders, obsessive-
compulsive disorder (OCD), and trauma-related disorders. No reviews on their differential …

Panic disorder is commonly prevalent in the population, but the treatment response for panic
disorder in clinical practice is much less effective than that in our imagination. Increasing …

The evidence-based pharmacotherapy of panic disorder continues to evolve. This paper
reviews data on first-line pharmacotherapy, evidence for maintenance treatment, and …

The objective of this study was to evaluate the efficacy and tolerability of extended release
quetiapine fumarate (quetiapine XR) as maintenance monotherapy for patients with …